Deep Blue Biotech
Founded 2023 · 6 employees on LinkedIn · 3 known investors
Deep Blue Biotech develops sustainable chemicals by re-engineering cyanobacteria to convert CO₂ into high-value molecules, using AI-driven metabolic modelling. Its products include an ocean-derived hyaluronic acid, targeting the cosmetics/ingredients and broader chemicals industry.
Founders & leadership
Investors · 3
Frequently asked questions
- What does Deep Blue Biotech do?
- Deep Blue Biotech develops sustainable chemicals by re-engineering cyanobacteria to convert CO₂ into high-value molecules, using AI-driven metabolic modelling. Its products include an ocean-derived hyaluronic acid, targeting the cosmetics/ingredients and broader chemicals industry.
- Who are Deep Blue Biotech's investors?
- Deep Blue Biotech's investors include Carbon13, One Planet Capital, Sustainable Ventures.